A detailed history of Edge Wealth Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Edge Wealth Management LLC holds 15,000 shares of TGTX stock, worth $483,000. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,000
Previous 15,000 -0.0%
Holding current value
$483,000
Previous $266,000 31.58%
% of portfolio
0.07%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

BUY
$32.5 - $48.96 $162,500 - $244,800
5,000 Added 50.0%
15,000 $586,000
Q1 2021

Apr 09, 2021

SELL
$41.61 - $54.3 $891,286 - $1.16 Million
-21,420 Reduced 68.17%
10,000 $482,000
Q4 2020

Jan 19, 2021

SELL
$25.27 - $54.9 $63,175 - $137,250
-2,500 Reduced 7.37%
31,420 $1.64 Million
Q3 2020

Oct 21, 2020

BUY
$18.49 - $27.24 $18,490 - $27,240
1,000 Added 3.04%
33,920 $908,000
Q2 2020

Aug 03, 2020

BUY
$8.9 - $21.84 $13,350 - $32,760
1,500 Added 4.77%
32,920 $641,000
Q2 2019

Jul 15, 2019

BUY
$6.27 - $8.65 $197,003 - $271,783
31,420 New
31,420 $270,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.